Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer
Gilead Sciences, Inc. announced that it has received all necessary regulatory approvals for its acquisition of Arcellx, including decisions from the Australian and Austrian competition authorities. Consequently, Gilead has extended its tender offer for all outstanding shares of Arcellx common stock to April 27, 2026. As of April 16, 2026, approximately 17.5% of Arcellx's shares have been tendered, with the offer price set at $115.00 per share cash plus contingent value rights.
Cardinal Health Inc. stock (US14149Y1082): Is supply chain resilience now the real test for steady returns?
Cardinal Health Inc. is positioned for stable growth in the U.S. healthcare sector due to its essential role in drug and medical product distribution, which benefits from rising healthcare spending and an aging population. The company's focus on efficient logistics and a diversified product portfolio, including pharmaceuticals and medical supplies, provides resilient demand that is less susceptible to economic fluctuations. While facing competition and regulatory pressures, Cardinal Health's market leadership and strategic investments aim to ensure consistent performance for investors.
This Texas Instruments Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday
This article highlights five significant analyst upgrades for various companies on Friday. Notably, a Mizuho analyst upgraded Texas Instruments from Underperform to Neutral, increasing the price target. Other companies receiving upgrades include Postal Realty Trust Inc., Onto Innovation Inc., Petroleo Brasileiro ADR, and Quaker Chemical Corp.
Former Verisk CEO Stephenson joins ZestyAI’s Board of Directors
ZestyAI, an AI-driven insurance risk analytics provider, has announced that Scott Stephenson, former Chairman, President, and CEO of Verisk Analytics, has joined its Board of Directors. Stephenson's appointment comes as the insurance industry transitions further into integrating artificial intelligence into decision-making. Both Stephenson and ZestyAI's CEO, Attila Toth, emphasize the importance of AI and proprietary data in shaping the future of risk understanding and management in the industry.
IT UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Gartner (IT) Investors of Securities Class Action Deadline on May 18, 2026
Faruqi & Faruqi, LLP is reminding Gartner (NYSE: IT) investors of the May 18, 2026 deadline to seek the role of lead plaintiff in a federal securities class action. The lawsuit alleges that Gartner made false and/or misleading statements regarding its growth rates and ability to meet consulting revenue targets and CV growth rates. This follows a significant drop in Gartner's stock price after the company reported Q4 2025 financial results and a disappointing 2026 outlook.
Airport Just Outside of Bucks County is Adding New Allegiant Flights
Trenton-Mercer Airport, located near Bucks County, is introducing 30 new nonstop routes to 35 cities through Allegiant Airlines starting in early 2026. This expansion aims to connect smaller cities to popular vacation destinations at affordable prices, building on Allegiant's mission. The new flights, including destinations like Fort Lauderdale-Hollywood, Punta Gorda, and St. Pete-Clearwater in Florida, signify significant growth for the airline and provide more travel options for residents.
Wright Investors Service Inc. Has $1.84 Million Stock Position in Arista Networks, Inc. $ANET
Wright Investors Service Inc. reduced its stake in Arista Networks (NYSE:ANET) by 52.3% in the fourth quarter, now holding 14,050 shares valued at $1.84 million. Despite this reduction and recent insider selling, Wall Street analysts maintain a "Buy" consensus rating for ANET with an average price target of $177.83, with some analysts setting targets as high as $200.00. Institutional investors collectively own a significant 82.47% of the company's stock.
Wright Investors Service Inc. Has $5.64 Million Position in Bristol Myers Squibb Company $BMY
Wright Investors Service Inc. increased its stake in Bristol Myers Squibb Company (NYSE:BMY) by 27.7% in the fourth quarter, now holding 104,570 shares valued at $5.64 million, making it their 15th largest holding. Other institutional investors also adjusted their positions in BMY. The company recently announced a quarterly dividend of $0.63 per share and reported earnings of $1.26 per share for the last quarter, missing analyst estimates.
AOI Expands Its Houston-Area Footprint to 900,000 Square Feet to Increase Capacity and Support Future Growth
Applied Optoelectronics, Inc. (AOI) announced a significant expansion of its Houston-area footprint, adding approximately 388,000 square feet in new facilities to support growing demand for optical connectivity in data centers. This expansion, bringing their total Houston-area capacity to 900,000 square feet, aims to increase manufacturing capability for 800G and 1.6T transceivers and expand laser fabrication capacity by 350% by the end of 2027. The move is strategic, aligning with AOI's goal to become a premier high-volume U.S. producer of AI-focused data center transceivers and optics.
Wright Investors Service Inc. Has $1.13 Million Stake in AT&T Inc. $T
Wright Investors Service Inc. significantly reduced its stake in AT&T Inc. by 59.3% in the fourth quarter, selling 66,277 shares and retaining 45,500 shares valued at approximately $1.13 million. Despite this reduction, AT&T's stock is largely held by institutional investors (57.1%) and has a "Moderate Buy" consensus rating with a target price of $30.74, following better-than-expected Q4 earnings and a declared quarterly dividend.








